}}</ref> but requested new studies as a prerequisite to approval, including a clinical trial in the elderly, a safety study comparing adverse effects to those of similarly marketed drugs, and a preclinical study examining indiplon's safety in the third trimester of pregnancy.<ref name="pressrelease1">{{Cite web|title=Additional Pipeline Projects |url=http://www.neurocrine.com/index.cfm?navId=25 |publisher=Neurocrine |date=2012-02-16 |archiveurl=http://www.webcitation.org/65VURNJ06?url=http://www.neurocrine.com/index.cfm?navId=25 |archivedate=2012-02-17 |deadurl=no |accessdate=2014-06-24 |df= }}</ref> 
